Characterization of secreted and intracellular forms of a truncated hepatitis C virus E2 protein expressed by a recombinant herpes simplex virus

Journal of General Virology

Volumn 84, Issue 3, 2003, Pages 545-554

  Lucas, M ^a,e   Tsitoura, E ^a   Montoya, M ^b   Laliotou, B ^a   Aslanoglou, E ^a   Kouvatsis, V ^a   Entwisle, C ^c   Miller, J ^c   Klenerman, P ^e   Hadziyannis, A ^d   Hadziyannis, S ^d   Borrow, P ^b   Mavromara, Penelope ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b EDWARD JENNER INST FOR VACC RES   (United Kingdom)

^c Cantab Pharmaceuticals Ltd   (United Kingdom)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD81 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; MONOCLONAL ANTIBODY; PROTEIN ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN SECRETION; PROTEIN SYNTHESIS; TH1 CELL; VIRUS GENE; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADOLESCENT; ADULT; AGED; ANIMALS; CELL LINE; FEMALE; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; SIMPLEXVIRUS; TRANSFECTION; VACCINATION; VIRAL ENVELOPE PROTEINS;

ANIMALIA; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 1; RNA VIRUSES; SIMPLEXVIRUS;

EID: 0037372112     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.18775-0     Document Type: Article

References (51)

1. Abrignani, S. & Rosa, D. (1998). Perspectives for a hepatitis C virus vaccine. Clin Diagn Virol 10, 181-185.
2. Brockman, M. A. & Knipe, D. M. (2002). Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity. J Virol 76, 3678-3687.
3. Buonocore, L., Blight, K. J., Rice, C. M. & Rose, J. K. (2002). Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins. J Virol 76, 6865-6872.
4. Chien, D. Y., Choo, Q. L., Tabrizi, A. & 16 other authors (1992). Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease. Proc Natl Acad Sci U S A 89, 10011-10015.
5. Chien, D. Y., Choo, Q. L., Ralston, R., Spaete, R., Tong, M., Houghton, M. & Kuo, G. (1993). Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 342, 933.
6. Choo, Q. L., Kuo, G., Ralston, R. & 15 other authors (1994). Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci U S A 91, 1294-1298.
7. Choukhi, A., Ung, S., Wychowski, C. & Dubuisson, J. (1998). Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins. J Virol 72, 3851-3858.
8. Choukhi, A., Pillez, A., Drobecq, H., Sergheraert, C., Wychowski, C. & Dubuisson, J. (1999). Characterization of aggregates of hepatitis C virus glycoproteins. J Gen Virol 80, 3099-3107.
9. Cocquerel, L., Meunier, J. C., Pillez, A., Wychowski, C. & Dubuisson, J. (1998). A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. J Virol 72, 2183-2191.
10. Cohen, J. (1999). The scientific challenge of hepatitis C. Science 285, 26-30.
11. Da Costa, X. J., Morrison, L. A. & Knipe, D. M. (2001). Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection. Virology 288, 256-263.
12. Deleersnyder, V., Pillez, A., Wychowski, C., Blight, K., Xu, J., Hahn, Y. S., Rice, C. M. & Dubuisson, J. (1997). Formation of native hepatitis C virus glycoprotein complexes. J Virol 71, 697-704.
13. Depraetere, S. & Leroux-Roels, G. (1999). Hepatitis C virus envelope proteins: immunogenicity in humans and their role in diagnosis and vaccine development. Viral Hep Rev 5, 113-146.
14. Dubuisson, J. (1998). The role of chaperone proteins in the assembly of envelope proteins of hepatitis C virus. Bull Mem Acad R Med Belg 153, 343-349.
15. Dubuisson, J., Hsu, H. H., Cheung, R. C., Greenberg, H. B., Russell, D. G. & Rice, C. M. (1994). Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol 68, 6147-6160.
16. Duvet, S., Cocquerel, L., Pillez, A., Cacan, R., Verbert, A., Moradpour, D., Wychowski, C. & Dubuisson, J. (1998). Hepatitis C virus glycoprotein complex localization in the endoplasmic reticulum involves a determinant for retention and not retrieval. J Biol Chem 273, 32088-32095.
17. Flint, M., Thomas, J. M., Maidens, C. M., Shotton, C., Levy, S., Barclay, W. S. & McKeating, J. A. (1999). Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. J Virol 73, 6782-6790.
18. Flint, M., Dubuisson, J., Maidens, C., Harrop, R., Guile, G. R., Borrow, P. & McKeating, J. A. (2000). Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein. J Virol 74, 702-709.
19. Forns, X., Emerson, S. U., Tobin, G. J., Mushahwar, I. K., Purcell, R. H. & Bukh, J. (1999). DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface. Vaccine 17, 1992-2002.
20. Forrester, A., Farrell, H., Wilkinson, G., Kaye, J., Davis-Poynter, N. & Minson, T. (1992). Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. J Virol 66, 341-348.
21. Fournillier-Jacob, A., Lunel, F., Cahour, A., Cresta, P., Frangeul, L., Perrin, M., Girard, M. & Wychowski, C. (1996). Antibody responses to hepatitis C envelope proteins in patients with acute or chronic hepatitis C. J Med Virol 50, 159-167.
22. Hoofnagle, J. H. (1997). Hepatitis C: the clinical spectrum of disease. Hepatology 26, 15S-20S.
23. Hussy, P., Faust, H., Wagner, J. C., Schmid, G., Mous, J. & Jacobsen, H. (1997). Evaluation of hepatitis C virus envelope proteins expressed in E. coli and insect cells for use as tools for antibody screening. J Hepatol 26, 1179-1186.
24. Lanford, R. E., Notvall, L., Chavez, D., White, R., Frenzel, G., Simonsen, C. & Kim, J. (1993). Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells. Virology 197, 225-235.
25. Latchman, D. S. (2001). Gene delivery and gene therapy with herpes simplex virus-based vectors. Gene 264, 1-9.
26. Lauer, G. M. & Walker, B. D. (2001). Hepatitis C virus infection. N Engl J Med 345, 41-52.
27. Lesniewski, R., Okasinski, G., Carrick, R., Van Sant, C., Desai, S., Johnson, R., Scheffel, J., Moore, B. & Mushahwar, I. (1995). Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia. J Med Virol 45, 415-422.
28. Lok, A. S., Chien, D., Choo, Q. L., Chan, T. M., Chiu, E. K., Cheng, I. K., Houghton, M. & Kuo, G. (1993). Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients. Hepatology 18, 497-502.
29. Loudon, P. T., Blakeley, D. M., Boursnell, M. E. & 7 other authors (2001). Preclinical safety testing of DISC-hGMCSF to support phase I clinical trials in cancer patients. J Gene Med 3, 458-467.
30. Matsuura, Y., Harada, S., Suzuki, R., Watanabe, Y., Inoue, Y., Saito, I. & Miyamura, T. (1992). Expression of processed envelope protein of hepatitis C virus in mammalian and insect cells. J Virol 66, 1425-1431.
31. Michalak, J. P., Wychowski, C., Choukhi, A., Meunier, J. C., Ung, S., Rice, C. M. & Dubuisson, J. (1997). Characterization of truncated forms of hepatitis C virus glycoproteins. J Gen Virol 78, 2299-2306.
32. Mink, M. A., Benichou, S., Madaule, P., Tiollais, P., Prince, A. M. & Inchauspe, G. (1994). Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library. Virology 200, 246-255.
33. Miriagou, V., Argnani, R., Kakkanas, A., Georgopoulou, U., Manservigi, R. & Mavromara, P. (1995). Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: protection studies against lethal viral infection in mice. J Gen Virol 76, 3137-3143.
34. Mita, E., Hayashi, N., Ueda, K., Kasahara, A., Fusamoto, H., Takamizawa, A., Matsubara, K., Okayama, H. & Kamada, T. (1992). Expression of MBP-HCV NS1/E2 fusion protein in E coli and detection of anti-NS1/E2 antibody in type C chronic liver disease. Biochem Biophys Res Commun 183, 925-930.
35. Mizushima, H., Hijikata, M., Asabe, S., Hirota, M., Kimura, K. & Shimotohno, K. (1994). Two hepatitis C virus glycoprotein E2 products with different C termini. J Virol 68, 6215-6222.
36. Op De Beeck, A., Cocquerel, L. & Dubuisson, J. (2001). Biogenesis of hepatitis C virus envelope glycoproteins. J Gen Virol 82, 2589-2595.
37. Pileri, P., Uematsu, Y., Campagnoli, S. & 8 other authors (1998). Binding of hepatitis C virus to CD81. Science 282, 938-941.
38. Psichogiou, M., Katsoulidou, A., Vaindirli, E., Francis, B., Lee, S. R. & Hatzakis, A. (1997). Immunologic events during the incubation period of hepatitis C virus infection: the role of antibodies to E2 glycoprotein. Multicentre Hemodialysis Cohort Study on Viral Hepatitis. Transfusion 37, 858-862.
39. Reed, K. E. & Rice, C. M. (2000). Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 242, 55-84.
40. Roizman, B. & Knipe, D. M. (2001). The replication of herpes simplex viruses. In Fields Virology, 4th edn, pp. 2399-2459. Edited by D. M. Knipe & P. M. Howley. Philadelphia: Lippincott Williams & Wilkins.
41. Saito, I., Miyamura, T., Ohbayashi, A. & 10 other authors (1990). Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 87, 6547-6549.
42. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, NY. Cold Spring Harbor Laboratory.
43. Saracco, G., Abate, M. L., Baldi, M. and others (1994). Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis. Liver 14, 65-70.
44. Shad, J. A. & McHutchison, J. G. (2001). Current and future therapies of hepatitis C. Clin Liver Dis 5, 335-359.
45. Siler, C. A., McGettigan, J. P., Dietzschold, B., Herrine, S. K., Dubuisson, J., Pomerantz, R. J. & Schnell, M. J. (2002). Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines. Virology 292, 24-34.
46. Tsitoura, E., Lucas, M., Revol-Guyot, V., Epstein, A. L., Manservigi, R. & Mavromara, P. (2002). Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors. J Gen Virol 83, 561-566.
47. Whitley, R. J. & Roizman, B. (2001). Herpes simplex virus infections. Lancet 357, 1513-1518.
48. Yokosuka, O., Omata, M., Ito, Y. & Ohto, M. (1993). Expression of HCV E2/NS1 protein as a fusion protein with maltose binding protein: detection of anti-E2/NS1 antibody in chronic liver disease. Gut 34, S64-65.
49. Yuki, N., Hayashi, N., Kasahara, A., Hagiwara, H., Mita, E., Ohkawa, K., Katayama, K., Fusamoto, H. & Kamada, T. (1996). Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection. Hepatology 23, 947-952.
50. Zaaijer, H. L., Vallari, D. S., Cunningham, M., Lesniewski, R., Reesink, H. W., van der Poel, C. L. & Lelie, P. N. (1994). E2 and NS5: new antigens for detection of hepatitis C virus antibodies. J Med Virol 44, 395-397.
51. Zucchelli, S., Capone, S., Fattori, E. & 8 other authors (2000). Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J Virol 74, 11598-11607.